BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9554973)

  • 1. Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity.
    Dalia A; Uretsky NJ; Wallace LJ
    Brain Res; 1998 Mar; 788(1-2):111-7. PubMed ID: 9554973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens.
    David HN; Abraini JH
    Neuropharmacology; 2001 Sep; 41(4):454-63. PubMed ID: 11543765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.
    Barik S; de Beaurepaire R
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):718-26. PubMed ID: 15913875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens.
    David HN; Abraini JH
    Eur J Neurosci; 2001 Jun; 13(11):2157-64. PubMed ID: 11422457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine regulation of extracellular glutamate in the nucleus accumbens.
    Kalivas PW; Duffy P
    Brain Res; 1997 Jun; 761(1):173-7. PubMed ID: 9247082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
    Dreher JK; Jackson DM
    Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine.
    Essman WD; McGonigle P; Lucki I
    Psychopharmacology (Berl); 1993; 112(2-3):233-41. PubMed ID: 7871025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists.
    Kaddis FG; Wallace LJ; Uretsky NJ
    Pharmacol Biochem Behav; 1993 Nov; 46(3):703-8. PubMed ID: 7506423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors.
    Bardgett ME; Henry JD
    Neuroscience; 1999; 94(1):59-70. PubMed ID: 10613497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Previous exposure to amphetamine enhances the subsequent locomotor response to a D1 dopamine receptor agonist when glutamate reuptake is inhibited.
    Kim JH; Perugini M; Austin JD; Vezina P
    J Neurosci; 2001 Mar; 21(5):RC133. PubMed ID: 11222671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM; Mohell N; Bengtsson A; Malmberg A
    Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats.
    Garrett BE; Holtzman SG
    Pharmacol Biochem Behav; 1994 Jan; 47(1):89-94. PubMed ID: 7906891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions.
    Wan RQ; Corbett R
    Neuropsychopharmacology; 1997 Apr; 16(4):259-68. PubMed ID: 9094143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locomotor bias produced by intra-accumbens injection of dopamine agonists and antagonists.
    Messier C; Mrabet O; Destrade C
    Pharmacol Biochem Behav; 1992 Jan; 41(1):177-82. PubMed ID: 1347172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
    Hoque KE; West AR
    Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced dopamine and glutamate neurotransmission in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory D2 autoreceptor function.
    Escobar AP; Cornejo FA; Olivares-Costa M; González M; Fuentealba JA; Gysling K; España RA; Andrés ME
    J Neurochem; 2015 Sep; 134(6):1081-90. PubMed ID: 26112331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA.
    Boldry RC; Willins DL; Wallace LJ; Uretsky NJ
    Brain Res; 1991 Sep; 559(1):100-8. PubMed ID: 1685936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of some dopamine and non-dopamine receptor ligands on amphetamine-induced changes in the rat brain neuropeptide Y system.
    Obuchowicz E; Herman ZS
    Pharmacol Rep; 2005; 57(6):850-5. PubMed ID: 16382207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
    Pierce RC; Kalivas PW
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.